Long-Term Impact of Lumacaftor/Ivacaftor Treatment on Cystic Fibrosis Disease Progression in Children 2 Through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2, Open-Label Clinical Trial.
primary studies published RCT
Details- 2024
- Stahl M
The application of the self-care deficit nursing theory in adolescents with cystic fibrosis: A randomized controlled study.
primary studies published RCT
Details- 2024
- Torun T
The effect of Lactobacillus reuteri on pulmonary function test and growth of cystic fibrosis patients.
primary studies published RCT
Details- 2024
- Tabatabaii SA
Efficacy and safety of LAU-7b in a Phase 2 trial in adults with cystic fibrosis.
primary studies published RCT
Details- 2024
- Konstan MW
Video based Direct Observation Physiotherapy (VDOP) in children with cystic fibrosis: A randomized controlled trial.
primary studies published RCT
Details- 2024
- Agarwal S
The cost of simplifying treatments for cystic fibrosis: Implications of the SIMPLIFY trial.
primary studies published RCT
Details- 2024
- Gold LS
Electronic home monitoring of children with cystic fibrosis to detect and treat acute pulmonary exacerbations and its effect on 1-year FEV(1).
primary studies published RCT
Details- 2024
- Yanaz M
Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis.
primary studies published RCT
Details- 2024
- McElvaney OJ
A randomized trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment.
primary studies published RCT
Details- 2024
- Waters V
Impact of 1-Year Supplementation with High-Rich Docosahexaenoic Acid (DHA) on Clinical Variables and Inflammatory Biomarkers in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial.
primary studies published RCT
Details- 2024
- Ayats-Vidal R